Alkem Labs Shares Slump 8% Despite Record Dividend, Modest Q3 Growth

• Alkem Labs shares fell over 8% despite declaring a record interim dividend of ₹43 per share.
• The decline was attributed to modest growth in the third quarter ended December 2025.
• Net profit increased 1.6% year-over-year to ₹636 crore, while revenue climbed 10.7% to ₹3,737 crore.
• EBITDA rose 9% to ₹826.8 crore, though margins slightly dipped to 22.1%.
• Alkem Labs plans to acquire a majority stake in Swiss company Occlutech Holding for €180 million by June 2026.